SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

13 May 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 281.73 millions against Rs. 287.63 millions recorded during the year-ago period.The Company has registered profit of Rs. 116.92  millions for the quarter ended March 2023, a growth of 19.46%  over Rs. 97.87 millions millions achieved in the corresponding quarter of last year.Operating profit surged to 163.25 millions from the corresponding previous quarter of 145.88 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 281.73 287.63 -2.05 1489.73 1148.54 29.71 1489.73 1148.54 29.71
Other Income 13.99 15.09 -7.29 60.24 40.50 48.74 60.24 40.50 48.74
PBIDT 163.25 145.88 11.91 802.42 620.96 29.22 802.42 620.96 29.22
Interest 0.25 1.79 -86.03 2.01 8.28 -75.72 2.01 8.28 -75.72
PBDT 163.00 144.09 13.12 800.41 612.68 30.64 800.41 612.68 30.64
Depreciation 7.69 5.44 41.36 25.76 22.33 15.36 25.76 22.33 15.36
PBT 155.31 138.65 12.02 774.65 590.35 31.22 774.65 590.35 31.22
TAX 38.39 40.78 -5.86 194.96 154.10 26.52 194.96 154.10 26.52
Deferred Tax 0.05 0.62 -91.94 2.55 0.72 254.17 2.55 0.72 254.17
PAT 116.92 97.87 19.46 579.69 436.25 32.88 579.69 436.25 32.88
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 57.95 50.72 14.25 53.86 54.07 -0.37 53.86 54.07 -0.37

Guj. Themis Biosyn Share Price

319.45 15.45 (5.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×